Concepedia

Yukiko Inada

YI

Statistics

Publications

7

Citations

138

H-Index

7

Active since

2016

Affiliations

University of Miyazaki Hospital(Current)

Kagoshima University

Kagoshima City Hospital

Kagoshima Medical Center

Kagoshima University Hospital

Yukiko Inada is an author at University of Miyazaki Hospital specializing in pharmacotherapy, antiviral therapy, and molecular virology.

Publications per year

2016–2022

7

Publications

7

Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection

Joji Toyota, Yoshiyasu Karino, Fumitaka Suzuki et al. · Journal of Gastroenterology · 2016 · 45 citations

, , +16

Effect of tolvaptan on the prognosis of patients with hepatic ascites

Yasunari Hiramine, Hirofumi Uto, Seiichi Mawatari et al. · Hepatology Research · 2019 · 20 citations

, , +13

The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir

Seiichi Mawatari, Kohei Oda, Kazuaki Tabu et al. · PLoS ONE · 2018 · 19 citations · Full text

, , +15

New resistance-associated substitutions and failure of dual oral therapy with daclatasvir and asunaprevir

Seiichi Mawatari, Kohei Oda, Kazuaki Tabu et al. · Journal of Gastroenterology · 2017 · 16 citations

, , +12

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

Graham R. Foster, Kazuaki Chayama, Wan‐Long Chuang et al. · SpringerPlus · 2016 · 14 citations · Full text

, , +15

1–5 of 7